SCHEMBL17123069

SCHEMBL17123069

c1cncc(-n2c3ccccc3c3ccc4ccncc4c32)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALOX12 P18054 1/20 0.42
▸ GFER P55789 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ CYP1A2 P05177 3/20 0.39
▸ METAP2 P50579 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ MAOA P21397 4/20 0.38
▸ MAOB P27338 4/20 0.38
▸ ACHE P22303 1/20 0.38
▸ MDM2 Q00987 1/20 0.38
▸ TOP2A P11388 1/20 0.37
▸ GSR P00390 1/20 0.37
▸ MAT2A P31153 3/20 0.36
▸ PRMT5 O14744 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17123072 0.92 KDM4E (0.49) ALOX12CYP1A2KDM4EATML3MBTL1
SCHEMBL15835511 0.92 GFER (0.45) ALOX12GFERNPSR1CYP1A2METAP2
SCHEMBL17989838 0.87 L3MBTL1 (0.53) ALOX12GFERNPSR1CYP1A2METAP2
SCHEMBL19359918 0.84 L3MBTL1 (0.53) ALOX12GFERNPSR1CYP1A2METAP2
SCHEMBL26841727 0.83 ALOX12 (0.47) ALOX12GFERNPSR1CYP1A2METAP2
SCHEMBL15945649 0.82 KDM4E (0.43) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL17989818 0.81 CYP1A2 (0.46) ALOX12GFERNPSR1CYP1A2METAP2
SCHEMBL19786521 0.81 ALOX12 (0.41) ALOX12GFERNPSR1CYP1A2METAP2
SCHEMBL18057954 0.80 MAPK10 (0.38) CYP1A2KDM4EATML3MBTL1MAOA
SCHEMBL16484319 0.80 KDM4E (0.59) ALOX12GFERNPSR1CYP1A2METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9825239-B2 Benzindolocarbazole derivative, light-emitting element material produced using same, and light-emitting element TORAY INDUSTRIES, INC. (JP) 2017-11-21 — — US disclosed
US-9825239-B2 Benzindolocarbazole derivative, light-emitting element material produced using same, and light-emitting element TORAY INDUSTRIES, INC. (JP) 2017-11-21 — — US disclosed
US-20150280140-A1 Benzindolocarbazole Derivative, Light-Emitting Element Material Produced Using Same, and Light-Emitting Element TORAY INDUSTRIES, INC. (JP) 2015-10-01 — — US disclosed
US-20150280140-A1 Benzindolocarbazole Derivative, Light-Emitting Element Material Produced Using Same, and Light-Emitting Element TORAY INDUSTRIES, INC. (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150280140-A1 Benzindolocarbazole Derivative, Light-Emitting Element Material Produced Using Same, and Light-Emitting Element L3MBTL4, L3MBTL1, IL4I1 ALOX12 390/4885GFER 791/4885NPSR1 4701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback